The CEOs of the region’s leading hospital systems and health plans who also represent the founding organizations of HEALTHeLINK, the Western New York Clinical Information Exchange, today launched a month-long drive to increase the number of completed patient consent/election forms.

BUFFALO, NY - About half of all cancer patients with metastatic disease will develop malignant pleural effusions (MPE), which result in significant respiratory challenges and a poorer overall quality of life. A lack of research data has hampered physicians’ efforts to effectively manage MPE.

BUFFALO, NY — Two Buffalo scientists have paired up to create technology that has the potential to revolutionize surgical training worldwide, developing the first procedure-based, hands-on surgical training software.

Surgeon/Engineer Team Produces World's First Procedure-Based Training Software for Robot-Assisted Surgery

BUFFALO, NY — A Buffalo-based international expert on robot-assisted surgical techniques has created the first-ever virtual instructional manual on robot-assisted surgery. The interactive guide, “Operative Manual of Robot-Assisted Urologic Surgery,” edited by Khurshid A.

Buffalo, NY — Men with metastatic prostate cancer who received the new biologic agent tasquinimod (TASQ) saw their progression-free survival time double compared to men who received a placebo, according to initial findings of a phase II clinical study to be presented by Roberto Pili, MD, Profes

BUFFALO, NY — Mikhail Nikiforov, PhD, an Associate Professor in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has been awarded a $750,000 grant from the American Cancer Society to develop new pharmaceutical agents to treat malignant melanoma, one of the most s